|
π¬
|
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.
A. Fluit,
Mark E. Jones,
F. Schmitz,
J. Acar,
Renu Gupta,
J. Verhoef
|
8 |
2000 |
8
π¬
|
|
π
|
An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial
15 auth.
C. Wood,
P. Srivastava,
R. Bukowski,
L. Lacombe,
A. Gorelov,
Sergei Gorelov,
P. Mulders,
H. ZieliΕski,
A. Hoos,
F. Teofilovici,
...
L. Isakov,
R. Flanigan,
R. Figlin,
Renu Gupta,
B. Escudier
|
8 |
2008 |
8
π
|
|
π
|
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
13 auth.
A. Testori,
J. Richards,
E. Whitman,
G. Mann,
J. Lutzky,
L. Camacho,
G. Parmiani,
G. Tosti,
J. Kirkwood,
A. Hoos,
...
Lianng Yuh,
Renu Gupta,
P. Srivastava
|
7 |
2008 |
7
π
|
|
π
|
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease
16 auth.
K. Olivier,
D. Griffith,
G. Eagle,
J. P. Mcginnis,
L. Micioni,
Keith Liu,
C. Daley,
K. Winthrop,
S. Ruoss,
D. Addrizzo-Harris,
...
P. Flume,
D. Dorgan,
M. Salathe,
B. Brown-Elliott,
Renu Gupta,
R. Wallace
|
7 |
2016 |
7
π
|
|
π
|
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial
17 auth.
G. Raghu,
B. van den Blink,
M. Hamblin,
A. Whitney Brown,
Jeffrey A. Golden,
Lawrence A. Ho,
M. Wijsenbeek,
M. VaΕ‘Γ‘kovΓ‘,
A. Pesci,
D.E. Antin-Ozerkis,
...
Keith C. Meyer,
M. Kreuter,
Hugues Santin-Janin,
G. Mulder,
B. Bartholmai,
Renu Gupta,
L. Richeldi
|
7 |
2018 |
7
π
|
|
π¬
|
Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease.
J. Adjemian,
D. R. Prevots,
J. Gallagher,
K. Heap,
Renu Gupta,
David E. Griffith
|
6 |
2014 |
6
π¬
|
|
π
|
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis
9 auth.
T. Walsh,
P. Whitcomb,
S. Piscitelli,
W. Figg,
S. Hill,
S. Chanock,
...
P. Jarosinski,
Renu Gupta,
P. Pizzo
|
6 |
1997 |
6
π
|
|
π’
|
Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection
10 auth.
O. Okusanya,
S. Bhavnani,
J. Hammel,
P. MiniΔ,
L. Dupont,
A. Forrest,
...
G. Mulder,
C. Mackinson,
P. Ambrose,
Renu Gupta
|
6 |
2009 |
6
π’
|
|
π¬
|
Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection
S. Rose,
M. Neville,
Renu Gupta,
L. Bermudez
|
6 |
2014 |
6
π¬
|
|
π¬
|
Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997
A. Fluit,
Mark E. Jones,
F. Schmitz,
J. Acar,
Renu Gupta,
J. Verhoef
|
6 |
2000 |
6
π¬
|
